MedPath

A prospective, single-centre study to investigate the role of Optical Coherence Tomography and fractional flow reserve for post coronary angioplasty stent optimisatio

Not Applicable
Conditions
Health Condition 1: I208- Other forms of angina pectoris
Registration Number
CTRI/2021/04/032543
Lead Sponsor
PGIMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients >= 18 and <= 75 years of age and undergoing PCI of native coronary arteries for stable ischemic heart disease

At least >=1 de novo lesions in a native coronary segment with a visually estimated diameter stenosis between >= 50 % and < 90%, and FFR <0.8 will be included

Patient understands and agrees to comply with all specified study requirements and provides written Informed Consent to this effect

Exclusion Criteria

Patients with USA/NSTEMI or ST elevation myocardial infarction

Clinical instability with compromised hemodynamics

Patients with a medical condition that limits the life expectancy to less than one year

Patients scheduled to undergo surgery within 3 months that requires interruption of DAPT

Women who are pregnant or planning to be pregnant

Patients with allergy to contrast agents

Patients with coronary artery bypass graft

Patients with a history of adverse reactions to aspirin, clopidogrel, or prasugrel

Patients in whom optimum OCT image acquisition is not feasible

Patients with chronic renal failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of OCT stent Optimization parameters with post PCI FFR (primary)Timepoint: immediately after the procedure
Secondary Outcome Measures
NameTimeMethod
MACE (cardiovascular death, non-fatal myocardial infarction or target vessel <br/ ><br>revascularization, CVA) at 6 months follow up (secondary)Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath